Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Ian Gordon Berry has worked on the following 5 EPO patent applications which have been published in the last five years:

EP12715421

THERAPEUTIC TREATMENT

IPC classification:
A61K 31/337, A61K 31/519, A61P 35/00
Applicant:
AstraZeneca AB
Agent:
Ian Gordon Berry, AstraZeneca PLC
Status:
GRANT OF PATENT INTENDED
EP12717456

CHROMENONE COMPOUNDS AS PI 3 -KINASE INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/5377, A61K 31/541, A61P 35/00, C07D 413/14, C07D 417/14
Applicant:
AstraZeneca AB
Agent:
Ian Gordon Berry, AstraZeneca PLC
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12759801

2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER

IPC classification:
A61K 31/437, A61K 31/506, A61P 35/00, C07D 401/02, C07D 471/04
Applicant:
AstraZeneca AB
Agent:
Ian Gordon Berry, AstraZeneca PLC
Status:
PATENT GRANTED
EP12727399

NOVEL TICAGRELOR CO - CRYSTAL

IPC classification:
A61K 31/519, A61P 7/02, C07D 487/04
Applicant:
AstraZeneca AB
Agent:
Ian Gordon Berry, AstraZeneca PLC
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14704881

COMBINATION THERAPY FOR THE TREATMENT OF NOSOCOMIAL PNEUMONIA

IPC classification:
A61K 31/4184, A61K 31/546, A61P 11/00
Applicant:
AstraZeneca AB
Agent:
Ian Gordon Berry, AstraZeneca PLC
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature